Evidence map›Paper›PMID 16786032›Full record

ArticleMolecular psychiatry2006

Impact of complex genetic variation in COMT on human brain function.

A Meyer-Lindenberg, T Nichols, J H Callicott, J Ding, B Kolachana, J Buckholtz, V S Mattay, M Egan, D R Weinberger

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 142 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
142citing papers in PubMed, 9 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

142 citing papers in PubMed, 9 syntheses or guidelines pooled it.

  1. International journal of molecular sciences · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Functional MRI in ADHD: a systematic literature review.Expert review of neurotherapeutics · 2007
    Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Trial
  13. COMT Val108/158Met polymorphism and the modulation of task-oriented behavior in children with ADHD.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2008
    Trial
  14. Article
  15. Molecular mechanisms of alcohol's effects on the human body: A review and update.Journal of biochemical and molecular toxicology · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

82 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

A Meyer-LindenbergUnit for Systems Neuroscience in Psychiatry, National Institute of Mental Health, NIH, DHHS, Bethesda, MD 20892-1257, USA. andreasml@nih.gov
T Nichols
J H Callicott
J Ding
B Kolachana
J Buckholtz
V S Mattay
M Egan
D R Weinberger

Funding

Genetic Basis Of Cortical Malfunction In SchizophreniaZIAMH002734 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI BERMAN, KAREN FAITH · 2009 to 2014
$17.5M
GENETIC BASIS OF CORTICAL MALFUNCTION IN SCHIZOPHRENIAZ01MH002734 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI WEINBERGER, DANIEL MARTIN · 1996 to 2008
$8.4M
Characterization of Genetic Mechanisms Contributing to Neuropsychiatric DisorderZIAMH002904 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI BERMAN, KAREN FAITH · 2009 to 2012
$8.1M
Biological Characterization of Genetic Mechanisms in Neuropsychiatric DisordersZ01MH002904 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI WEINBERGER, DANIEL · 2007 to 2008
$2.6M
Neural mechanisms for genetic contributions to psychiatric disease and behaviorZ01MH002867 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI MEYER-LINDENBERG, ANDREAS · 2006 to 2007
$1.8M
6 · The paper itself

Abstract

Catechol-O-methyltransferase (COMT) has been shown to be critical for prefrontal dopamine flux, prefrontal cortex-dependent cognition and activation. Several potentially functional variants in the gene have been identified, but considerable controversy exists regarding the contribution of individual alleles and haplotypes to risk for schizophrenia, partly because clinical phenotypes are ill-defined and preclinical studies are limited by lack of adequate models. Here, we propose a neuroimaging approach to overcome these limitations by characterizing the functional impact of ambiguous haplotypes on a neural system-level intermediate phenotype in humans. Studying 126 healthy control subjects during a working-memory paradigm, we find that a previously described risk variant in a functional Val158Met (rs4680) polymorphism interacts with a P2 promoter region SNP (rs2097603) and an SNP in the 3' region (rs165599) in predicting inefficient prefrontal working memory response. We report evidence that the nonlinear response of prefrontal neurons to dopaminergic stimulation is a neural mechanism underlying these nonadditive genetic effects. This work provides an in vivo approach to functional validation in brain of the biological impact of complex genetic variations within a gene that may be critical for its clinical association.

Indexed as

Genetic VariationPolymorphism, Single NucleotideAdultAmino Acid SubstitutionBase SequenceBrainCatechol O-MethyltransferaseDopamineFemaleHumansIntronsMaleMemoryPolymorphism, GeneticPrefrontal CortexReaction TimeCatechol O-MethyltransferaseDopamine

Identifiers

PMID16786032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.